The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Lipsitz, J. D.
* Articles by Gorman, J. M.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Lipsitz, J. D.
* Articles by Gorman, J. M.

Am J Psychiatry 1994; 151:1662-1668
Copyright © 1994 by American Psychiatric Association


REGULAR ARTICLES

Psychopathology in male and female intravenous drug users with and without HIV infection

JD Lipsitz, JB Williams, JG Rabkin, RH Remien, M Bradbury, W el Sadr, R Goetz, S Sorrell and JM Gorman
HIV Center for Clinical and Behavioral Studies, New York State Psychiatric Institute, New York.

OBJECTIVE: The authors report on results of systematic clinical assessment of psychopathology among HIV-positive and HIV-negative intravenous drug users. METHOD: As part of a multidisciplinary baseline assessment, 147 male (85 HIV-positive and 62 HIV-negative) and 76 female (39 HIV-positive and 37 HIV-negative) intravenous drug users were evaluated with the Structural Clinical Interview for DSM-III-R and measures of psychiatric symptom severity, global functioning, and stress. RESULTS: Prevalence of a diagnosis of current depression (26%) and severity of depressive and anxiety symptoms in both HIV-positive and HIV-negative subjects were greater than in the general community, but not greater than in other studies of intravenous drug users. HIV- positive men had a higher prevalence of depressive disorders than HIV- negative men (33% and 16%, respectively), although this pattern was not found among women (26% and 30%). Diagnosis of depressive disorders and severity of depressive and anxiety symptoms were associated with a symptom-based measure of HIV illness stage, but not with indices of immune functioning (CD4+ cell count and CD4+ cell percent). CONCLUSIONS: Despite selective associations between HIV illness variables and depression, high rates of depression across HIV status in this cohort suggest that intravenous drug use and associated factors are more salient than HIV illness factors in understanding psychopathology in this population.


This article has been cited by other articles:


Home page
Clin Child Psychol PsychiatryHome page
D. A. Murphy
HIV-positive Mothers' Disclosure of Their Serostatus to Their Young Children: A Review
Clinical Child Psychology and Psychiatry, January 1, 2008; 13(1): 105 - 122.
[Abstract] [PDF]


Home page
J Am Board Fam MedHome page
R. B. Goldstein, M. O. Johnson, M. J. Rotheram-Borus, S. B. Kirshenbaum, R. M. Pinto, L. Kittel, W. Pequegnat, J. D. Mickalian, L. S. Weinhardt, J. A. Kelly, et al.
Psychological Distress, Substance Use, and Adjustment among Parents Living with HIV
J Am Board Fam Med, September 1, 2005; 18(5): 362 - 373.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
M. F. Morrison, J. M. Petitto, T. T. Have, D. R. Gettes, M. S. Chiappini, A. L. Weber, P. Brinker-Spence, R. M. Bauer, S. D. Douglas, and D. L. Evans
Depressive and Anxiety Disorders in Women With HIV Infection
Am J Psychiatry, May 1, 2002; 159(5): 789 - 796.
[Abstract] [Full Text] [PDF]


Home page
AIDS Clin CareHome page
Psychiatric Aspects of HIV Care
AIDS Clinical Care, November 1, 2001; 2001(1101): 6 - 6.
[Full Text]


Home page
Arch Gen PsychiatryHome page
E. G. Bing, M. A. Burnam, D. Longshore, J. A. Fleishman, C. D. Sherbourne, A. S. London, B. J. Turner, F. Eggan, R. Beckman, B. Vitiello, et al.
Psychiatric Disorders and Drug Use Among Human Immunodeficiency Virus-Infected Adults in the United States
Arch Gen Psychiatry, August 1, 2001; 58(8): 721 - 728.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
J. R. Ickovics, M. E. Hamburger, D. Vlahov, E. E. Schoenbaum, P. Schuman, R. J. Boland, J. Moore, and for the HIV Epidemiology Research Study Group
Mortality, CD4 Cell Count Decline, and Depressive Symptoms Among HIV-Seropositive Women: Longitudinal Analysis From the HIV Epidemiology Research Study
JAMA, March 21, 2001; 285(11): 1466 - 1474.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
J. G. Rabkin, G. J. Wagner, and R. Rabkin
Fluoxetine Treatment for Depression in Patients With HIV and AIDS: A Randomized, Placebo-Controlled Trial
Am J Psychiatry, January 1, 1999; 156(1): 101 - 107.
[Abstract] [Full Text]


Home page
Psychiatr. Serv.Home page
H. A. Swartz, J. C. Markowitz, and M. C. Sewell
Psychosocial Characteristics of Pregnant and Non pregnant HIV-Seropositive Women
Psychiatr Serv, December 1, 1998; 49(12): 1612 - 1614.
[Abstract] [Full Text] [PDF]


Home page
PsychosomaticsHome page
L. Grassi, R. Righi, L. Sighinolfi, S. Makoui, and F. Ghinelli
Coping Styles and Psychosocial-Related Variables in HIV-Infected Patients
Psychosomatics, August 1, 1998; 39(4): 350 - 359.
[Abstract] [Full Text]


Home page
Arch Gen PsychiatryHome page
J. Leserman, J. M. Petitto, D. O. Perkins, J. D. Folds, R. N. Golden, and D. L. Evans
Severe Stress, Depressive Symptoms, and Changes in Lymphocyte Subsets in Human Immunodeficiency Virus--Infected Men: A 2-Year Follow-up Study
Arch Gen Psychiatry, March 1, 1997; 54(3): 279 - 285.
[Abstract] [PDF]


Home page
Arch Gen PsychiatryHome page
J. G. Johnson, J. B. W. Williams, R. R. Goetz, J. G. Rabkin, R. H. Remien, J. D. Lipsitz, and J. M. Gorman
Personality Disorders Predict Onset of Axis I Disorders and Impaired Functioning Among Homosexual Men With and at Risk of HIV Infection
Arch Gen Psychiatry, April 1, 1996; 53(4): 350 - 357.
[Abstract] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 1994 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org